

A simple and reproducible method for determination of diltiazem in bulk and in dosage forms is presented. The method is based on formation of hydroxamic acid, which reacts with iron (III), forming a complex with a maximum absorption at 525nm. Assay procedure for diltiazem dosage form requires thin-layer chromatographic separation prior to colorimetric analysis.
| EMTREE drug terms: | cortiazem retarddiltiazemunclassified drug |
|---|---|
| EMTREE medical terms: | articlecomplex formationdrug determinationspectrophotometry |
| MeSH: | Chromatography, Thin LayerDiltiazemSpectrophotometryTablets |
diltiazem, 33286-22-5, 42399-41-7;
Diltiazem, 42399-41-7; Tablets
Drug manufacturer:
goedecke, Germany;
inex, Yugoslavia
Zivanov-Stakic, D.; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Dr. Subotica 8, Yugoslavia
© Copyright 2004 Elsevier B.V., All rights reserved.